ADVANCES IN DIABETES TECHNOLOGY: A FOCUS ON CONTINUOUS GLUCOSE MONITORING 9:15 10:15 AM
|
|
- Mary Rodgers
- 5 years ago
- Views:
Transcription
1 ADVANCES IN DIABETES TECHNOLOGY: A FOCUS ON CONTINUOUS GLUCOSE MONITORING 9:15 10:15 AM ACPE UAN: L01-P 0.1 CEU/1 hr Activity Type: Knowledge-Based Learning Objectives for Pharmacists: Upon completion of this CPE activity participants should be able to: 1. Describe the limitations of self-management of blood glucose and the impact continuous glucose monitoring (CGM) has on diabetes management decisions. 2. Identify patients who would benefit from professional and/or personal CGM. 3. Differentiate among the available CGMs in terms of technical features, benefits and limitations, device compatibility and ease of use. 4. Describe how to utilize the available CGMs in terms of data sharing and data supporting dosing decisions. 5. Integrate relevant real-time and retrospective CGM data and device information into pharmacy practice and management decisions. Speaker: Erin Newkirk, PharmD, BCPS, CDE Erin Newkirk received her PharmD degree from the University of Wisconsin in 2001 and completed a Specialized Residency in Primary Care at the William S. Middleton Memorial Veterans Hospital in Madison, Wisconsin in She practiced at the University of Iowa Hospital and Clinics for 6 years before starting at Froedtert & The Medical College of Wisconsin in Erin has been working in the Endocrine clinic for the past 7 years and is currently spending most of her time working with patients with diabetes who utilize an insulin pump and/or continuous glucose monitor. She has previously worked within Anticoagulation, Transplant, Anemia, Pulmonary and Internal Medicine clinics. Erin has a passion for improving diabetes outcomes and is a certified diabetes educator. Speaker Disclosure: Erin Newkirk reports no actual or potential conflicts of interest in relation to this CPE activity. Off-label use of medications will not be discussed during this presentation.
2 JUNE 7, 2018 DES MOINES, IA Advancements in Diabetes Technology: A Focus on Continuous Glucose Monitoring Erin Newkirk, PharmD, BCPS, CDE Clinical Pharmacist, Endocrine clinic 1
3 Disclosure Statement Dr. Newkirk reports they have no actual or potential conflicts of interest associated with this presentation. CPE Learning Objective Describe the limitations of self-management of blood glucose and the impact continuous glucose monitoring (CGM) has on diabetes management decisions Identify patients who would benefit from professional and/or personal CGM Differentiate among the available CGM in terms of technical features, benefits and limitations, device compatibility and ease of use Describe how to utilize the available CGMs in terms of data sharing and data supporting dosing decisions Integrate relevant real-time and retrospective CGM data and device information into pharmacy practice and management decisions 2
4 CGM devices are available that have a FDA indication for the replacement of finger sticks for making diabetes treatment decisions A. True B. False CGM devices are available that have a FDA indication for the replacement of finger sticks for making diabetes treatment decisions A. True B. False 3
5 History of Monitoring Glycemic Control 1960s dipstix 2006: 1 st CGM 1980s Blood Glucose Meter Why CGM? Which plane would you rather fly for 15 hours? 4
6 Varying Patterns for A1c = 7% Brown A, Kennedy L, Runge A, Close K Going Beyond A1c One Outcome Can t Do It All. diatribe [Web site]. Sept Accessed April 8, 2018 Time in Range: Another Important Parameter Brown A, Kennedy L, Runge A, Close K Going Beyond A1c One Outcome Can t Do It All. diatribe [Web site]. Sept Accessed April 8,
7 Evidence Supports the Value of CGM Multiple studies have demonstrated the clinical benefit of currently available CGM devices More time in range Less hyper or hypoglycemia Decrease in nocturnal hypoglycemia Lower HbgA1c without added hypoglycemia Baily TS et al Diabetes Technol Ther 2007; 9(3): Garg S et al. Diabetes Care 2006: 29(1): Deiss D et al. Diabetes Care. 200; 29 (12): Hirsch IB, et al. Diabetes Technol Ther. 2008;10(4): ; Bolinder J, et al. Lancet. 2016; 388(10057): Haak, Thomas, et aldiabetes Therapy 8.1 (2017): CGM: Recognized by Professional Societies as Standard of Care American Diabetes Association 2018 CGM + intensive insulin in type 1 diabetes (age 18) to lower A1c and prevent hypoglycemia Can be helpful in lowering A1c in children, teenagers, younger adults American Association of Clinical Endocrinologists (AACE) 2015 CGM use has improved clinical diabetes outcomes by reducing hypoglycemia CGM should be used in all patients who have severe hypoglycemia Consensus of experts calls for wider use of CGM Endocrine Society 2016 Recommends CGM technology in adults and pediatrics with type 1 diabetes CGMs can be used on a short-term, intermittent basis for individuals with type 2 diabetes whose blood glucose is above targeted levels American Diabetes Association. Standard of Medical Care in Diabetes 2018 Glycemic targets Diabetes Care Jan; 41 (supplement 1): S55-S64. AACE/ACE Consensus Statement: 2016 Outpatient Glucose monitoring Consensus Statement. Endocr Pract 2016; 22: Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy & CGM in adults: An Endocrine Society Clinical Practice Guideline The Journal of Clin Endocr & Metab (11):
8 CGM Components Lag Time: Blood Glucose vs Sensor Glucose Train goes uphill, upward trend in glucose Train goes downhill, downward trend in glucose Accessed 4/8/18 7
9 What Types of Data Will We Get? Real-time data Immediate action points Therapeutic CGM data Can be used alone to make treatment decisions Dexcom G5 and G6 Freestyle Libre Retrospective data Identify patterns, fine-tune therapy, behavioral interventions FDA expands indication for continuous glucose monitoring system, first to replace fingerstick testing for diabetes treatment decisions. Food & Drug Administration. Published December 20, Accessed April 8, 2018 FDA approves first continuous glucose monitoring system for adults not requiring blood sample calibration. Food & Drug Administration. Published September 27, Accessed April 8 th, 2018 Real-Time Data: Arrow Indicators Rising Glucose SG 160 mg/dl and glucose is rising at a rate of 3+ mg/dl/min. Within 30 minutes the glucose level will be 250mg/dl Reacting to this trend arrow by administering more insulin can help prevent elevated glucose Falling Glucose SG 130 mg/dl and glucose is falling at a rate of 3+ mg/dl/min Within 30 minutes the glucose level will be ~40 mg/dl Reacting to this trend arrow by eating 15 grams of a fast acting carb could prevent hypoglycemia 8
10 Who is the Ideal Patient for Personal or Professional CGM? Intensive insulin regimen Frequent hypoglycemia Hypoglycemia unawareness Excessive glucose variability Varying and/or intensive activity Patient is 2 years of age or older Pregnant or wants to get pregnant Desire to improve glycemic control Desire to understand behaviors that influence glycemic control J. Endocr. Soc ;1(12): doi: /js Why not just go directly to personal CGM device? 9
11 Professional CGM Comparison Patient Case: CGM SH is a 72 YOF with type 1 diabetes who presents to endocrine clinic for professional CGM evaluation. She was referred due to suboptimal A1c, recurrent hypoglycemia, and hypoglycemia unawareness. She reported using glucagon 1-3 times per month for the past year with some episodes resulting in the paramedics being called. 10
12 Patient Case: Professional CGM Meter Log Before CGM Target: mg/dl % below target 11% % within target 40% % above target 49% Patient Case: CGM SH returns 3 months after receiving personal CGM No glucagon use or paramedic calls Less rebound hyperglycemia following hypoglycemia Decreased alcoholic intake; eats complex carb/protein snack with alcohol to prevent low BG Rarely stops insulin pump manually for low BG Decreased anxiety over fear of hypoglycemia Feels more comfortable participating in activities she enjoys 11
13 Patient Case: CGM Order of Priority 1. Prevent hypoglycemia 2. Achieve fasting glucose targets 3. Target post-prandial glucose As HgbA1c approaches goal, post-prandial glucose are the main contributor to hyperglycemia 12
14 CGM Users Have Lower HgbA1c Regardless of Insulin Delivery Method R KM, et al. Diabetes Care. 2015;38: Types of Personal CGM Stand-alone CGM Dexcom G4 Platinum G5 Mobile G6 Freestyle Libre Flash glucose monitoring Requires scanning Medtronic Guardian Connect 3 Mobile device only Combination Pump & CGM Dexcom TandemT:Slim X2/Dexcom G5 No options for autobasal adjustments based on CGM data Make treatment decisions with CGM data Medtronic 530G & 630G Enlite sensors 670G Guardian 3 sensors Option for basal automode based on CGM data No treatment decisions with CGM data 13
15 Dexcom G5 personal CGM Dexcom G5 14
16 Dexcom: Event Entries Trend Arrow Glucose Change From: A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System for the Management of Adults With Diabetes J. Endocr. Soc. 2017;1(12): doi: /js
17 Dexcom G5 : Adjusting Insulin Doses using Trend Arrows Post-prandial Monitoring & Treatment Using Dexcom G5 Trend arrows up to 4 hours 16
18 LEARNING ASSESSMENT QUESTION KL is about to eat 36 grams of carbs and dose 3 units of rapid acting insulin for her lunch (I:C ratio 1:12). Her current sensor glucose is 220 mg/dl and her correction factor is 40 mg/dl with a target glucose is 100 mg/dl which calculates out to 3 units. Her Dexcom G5 trend arrow shows ( with CF between 25 - <50 indicates +2.5 unit insulin dose adjustment). What amount of insulin should she receive 15 minutes before lunch? Which action would most benefit AG? a. 8.5 units of rapid acting insulin b. 6 units of rapid acting insulin c. 5.5 units of rapid acting insulin d. 3 units of rapid acting insulin LEARNING ASSESSMENT QUESTION KL is about to eat 36 grams of carbs and dose 3 units of rapid acting insulin for her lunch (I:C ratio 1:12). Her current sensor glucose is 220 mg/dl and her correction factor is 40 mg/dl with a target glucose is 100 mg/dl which calculates out to 3 units. Her Dexcom G5 trend arrow shows ( with CF between 25 - <50 indicates +2.5 unit insulin dose adjustment). What amount of insulin should she receive 15 minutes before lunch? Which action would most benefit AG? a. 8.5 units of rapid acting insulin b. 6 units of rapid acting insulin c. 5.5 units of rapid acting insulin d. 3 units of rapid acting insulin 17
19 Dexcom: Data Sharing Dexcom Clarity: Receiver: Must use website Dexcom G4 Share & Medicare G5 users to share data with clinic Need cable Dexcom G5 Mobile app Bluetooth-data automatically uploads to clarity if set up to share data Weekly notifications of key data via smartphone or Dexcom Studio: Professional G4 Receiver: Must use website Need cable Reset receiver Option to blind device Dexcom Follow app G5, non-medicare Up to 5 people can remotely monitor glucose data Recent FDA approval: Dexcom G6 No fingerstick calibration when using start-up calibration code Found on bottom of applicator on the adhesive strip Verily Dexcom 1 st generation: Easy-to-use, push-button applicator compared to current syringe-like plunger device 10-day sensor life (vs 7 days with G5) Mandatory shutoff No interference with acetaminophen (Tylenol) Urgent low soon alarm: a new feature will alert the user when blood glucose is dropping rapidly and is expected to cross the low threshold will occur within 20 minutes in advance of a potential severe low (55 mg/dl). 1 st integrated CGM or icgm Seamless integration with other diabetes devices Quicker FDA review process for future icgms Targeted ship date: June 2018 No timeline for Medicare approval yet Accessed 4/8/18 18
20 FreeStyle Libre personal: Flash Glucose Monitoring FreeStyle Libre: Sensor Basics 19
21 Freestyle Libre FreeStyle Libre: Glucose Reporting 20
22 Freestyle Libre Trend Arrows Check Glucose: or arrows, low glucose, glucose going low, no arrow, no glucose or sensor reading does not make sense Libreview: Data Sharing Connect reader via cable to computer to upload data Not compatible with Glooko/Diasend Personal Freestyle libre: Invite to upload from home link or provide practice ID Can set up patient dashboard to flag patients 21
23 Medtronic: Continuous Glucose Monitoring Accessed 4/18/18 Medtronic: Sensor Basics Accessed 4/8/18 22
24 Medtronic CGM Comparison MiniMed 670G w/guardian Sensor 3 Suspends insulin delivery when BG reaches low glucose limit Resumes delivery when SG levels are at least 20 mg/dl above low limit, or > 40 mg/dl above limit within 30 minutes Proactively suspends insulin: When SG value at or within 70 mg/dl above low limit When SG predicted to reach or fall below level that is > 20 mg/dl low limit within 30 minutes Resumes delivery when SG levels recover (see above), or after 2 hours of suspension Uses target of 120 mg/dl May be adjusted to 150 mg/dl temporarily Reads sensor glucose; adjusts basal rate every 5 minutes May recommend bolus dose if entering BG > 150 mg/dl 23
25 Medtronic: Trend Arrows SG = Sensor Glucose Accessed April 8, 2018 Carelink: Medtronic Data Sharing Carelink Personal Contour Next Link Meter (Reimbursement Support Program ) Link carelink personal account allows clinic to see data Clinic-Carelink Web: upload via CareLink USB device Guardian Connect (stand alone CGM): Turn on Sync to carelink for automatic uploads Up to 5 care partners can view CareLink data & receive customized text message notifications MiniMed Connect (530G pump): automatic uploads to CareLink Personal software Up to 3 Care partners can view CareLink data & receive customized text message notifications Not compatible with Glooko/Diasend Accessed April 8,
26 MARD: CGM Comparisons CGM Placement Billing 25
27 CGM Reimbursement Qualified Clinic Member Ambulatory CGM for a minimum of 72 hours; sensor placement, hook-up, calibration of monitor, patient training, removal of sensor, and printout of recording 95249: patient provided equipment Billed once/device 95250: office provided equipment Billed 2-6 times/year Physician, Physician Assistant, Nurse Practitioner CGM data Interpretation 95251: patient or office equipment With or without patient in office E/M in addition on the same day when a significant and separately identifiable service took place CGM data interpretation (95251) can be billed on an ongoing basis F:\Committees\SEGA\Socioeconomics & Member Advocacy\Website\Website Updates 2018\New and Revised CGM codes for Accessed 4/8/18 CMS FC; Medicare Physician Fee Schedule Final Rule, Addendum B updates CY2018. Conversion Factor Professional CGM Work-flow: Outpatient Pharmacy 26
28 Personal CGM: Coverage & Cost Commercial Insurance Freestyle Libre: Walmart, Walgreens, CVS, Kroeger, Rite-aide If sensors >$75/month: consumer customer service Dexcom: Dexcom vs distributor vs Specialty pharmacy Medtronic: medtronic or distributor Medicare coverage: Dexcom G5 & FreeStyle Libre through distributor only Must test BG levels 4x/day Multiple daily insulin injections ( 3/day) Visit in 6 months ago then every 6 months Medicaid coverage: Dexcom G5 (select cases) Personal CGM Selection Type 1 vs Type 2 Hypoglycemia/Alarms Calibrations Therapeutic CGM Ease of Use Pump user Insurance/Cost 27
29 Home CGM Continuation in Hospitalized Patients? Off-label use Institutional Procedures and guidelines should be developed Patient Waivers Sensors should be removed prior to CT, MRI or X- rays Remove reusable transmitters from sensors to avoid accidental disposal CGM in Hospitalized Patients Accuracy Changes in ph, hematocrit levels, blood oxygen tension, peripheral perfusion Substance interference Who will interpret data and make treatment decisions? How will CGM data be communicated to the nurse? What portions of data should be recorded and archived in the medical record? 28
30 The Role of the Pharmacist Identify appropriate patients for CGM through pharmacy records and patient interviews Educate patients regarding CGM Develop CGM programs for professional and/or personal CGM Medication Experts Understanding the mechanism and impact are a key component to CGM interpretation CGM is a mechanism for making drug therapy recommendations Questions? Erin Newkirk, PharmD, BCPS, CDE Clinical Pharmacist, Endocrine clinic 29
Insulin Pumps and Continuous Glucose Sensors- Embracing Technology. Susan Cavalier, BS, RN, CDE Manager, Diabetes Educator Sanford Diabetes Education
Insulin Pumps and Continuous Glucose Sensors- Embracing Technology Susan Cavalier, BS, RN, CDE Manager, Diabetes Educator Sanford Diabetes Education Diabetes Management Tools in 1974 Insulin pump history
More informationAbbott FreeStyle Libre Pro System
, the Professional CGM Abbott FreeStyle Libre Pro Reader Kit includes: Reader, USB cable, interactive tutorial on USB, and power adapter, user s manual, Quick Start Guide, Quick Reference Guide Kit includes:
More informationAbbott FreeStyle Libre Pro System
Professional CGM Abbott FreeStyle Libre Pro Reader Kit includes: Reader, USB cable, interactive tutorial on USB, and power adapter, user s manual, Quick Start Guide, Quick Reference Guide Kit includes:
More informationCareLink. software REPORT REFERENCE GUIDE. Management Software for Diabetes
CareLink Management Software for Diabetes software REPORT REFERENCE GUIDE How to use this guide Each type of CareLink report and its components are described in the following sections. Report data used
More informationContinuous Glucose Monitors for Diabetes Management
Continuous Glucose Monitors for Diabetes Management Ryan Huang, DO PGY II, Sonia Garcia-Jayne, DO PGY II Mandeep Gill, DO PGY I, Justin Leeka, DO, PGY I, Catherine Nguyen OMS IV Family Medicine Residency,
More informationToday s Goals 10/6/2017. New Frontiers in Diabetes Technology. Disclosures
New Frontiers in Diabetes Technology Marie E. McDonnell, MD Director, Brigham and Women's Diabetes Program Division of Endocrinology, Diabetes and Hypertension Brigham and Women s Hospital Today s Goals
More informationReport Reference Guide
Report Reference Guide How to use this guide Each type of CareLink report and its components are described in the following sections. Report data used to generate the sample reports was from sample patient
More informationNEW TECHNOLOGIES FOR MANAGING DIABETES ANGELA THOMPSON DNP, FNP-C, BC-ADM, CDE, FAANP
NEW TECHNOLOGIES FOR MANAGING DIABETES ANGELA THOMPSON DNP, FNP-C, BC-ADM, CDE, FAANP No commercial support or sponsorship was received for this project I have nothing to disclose OBJECTIVES Identify at
More informationIncorporating CGM Into Clinical Decision Making. Etie Moghissi, MD, FACE Clinical Associate Professor, David Geffen School of Medicine UCLA
Incorporating CGM Into Clinical Decision Making Etie Moghissi, MD, FACE Clinical Associate Professor, David Geffen School of Medicine UCLA 1 Limitations of Current Glucose Monitoring Methods A1c Standard
More informationQUESTION 4. WHAT CLINICAL DATA ARE CURRENTLY AVAILABLE TO SUPPORT EXPANDED CGM COVERAGE BY PAYERS AS PERTAINS TO QUESTIONS 1 AND 3?
500 1 QUESTION 4. WHAT CLINICAL DATA ARE CURRENTLY AVAILABLE TO SUPPORT EXPANDED CGM COVERAGE BY PAYERS AS PERTAINS TO QUESTIONS 1 AND 3? WHAT ADDITIONAL DATA ARE NEEDED? AACE/ACE CGM Consensus Conference:
More informationDiabetes II Insulin pumps; Continuous glucose monitoring system (CGMS) Ernest Asamoah, MD FACE FACP FRCP (Lond)
Diabetes II Insulin pumps; Continuous glucose monitoring system (CGMS) Ernest Asamoah, MD FACE FACP FRCP (Lond) 9501366-011 20110401 Objectives Understand the need for insulin pumps and CGMS in managing
More informationDiabetes Technology Update. Sarah Konigsberg, MD Diabetes & Endocrine Assoc. April 7, 2018
Diabetes Technology Update Sarah Konigsberg, MD Diabetes & Endocrine Assoc. April 7, 2018 Disclosures None No future technologies are FDA approved Continuous Glucose Monitors Continuous Glucose Monitors
More informationUSING THE MINIMED 670G SYSTEM
USING THE MINIMED 670G SYSTEM Instructions for the Experienced MiniMed 630G System User USING THE MINIMED 670G SYSTEM: INSTRUCTIONS FOR THE EXPERIENCED USER Checklist for starting on your MiniMed 670G
More informationWelcome to CareLink Pro
Reference Guide Welcome to CareLink Pro This guide was developed to serve as a reference for obtaining patient data and reviewing CareLink Pro reports. Getting Started with CareLink Pro Adding New Patients
More informationDISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.
DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this
More informationMEDICAL POLICY Continuous Glucose Monitoring Systems and Insulin Pumps
POLICY: PG0177 ORIGINAL EFFECTIVE: 12/01/08 LAST REVIEW: 05/24/18 MEDICAL POLICY Continuous Glucose Monitoring Systems and Insulin Pumps GUIDELINES This policy does not certify benefits or authorization
More informationAdvances in Diabetes Care Technologies
Advances in Diabetes Care Technologies 1979 2015 Introduction Roughly 20% to 30% of patients with T1DM and fewer than 1% of insulin-treated patients with T2DM use an insulin pump In 2007, the U.S. FDA
More informationFAQs for HCP segment New Instructions for Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System Non-Adjunctive Indication
FAQs for HCP segment New Instructions for Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System Non-Adjunctive Indication Q1. The Dexcom G5 Mobile System is the first CGM System to receive FDA approval
More informationTHE MINIMED 670G SYSTEM SCHOOL NURSE GUIDE
THE MINIMED 670G SYSTEM SCHOOL NURSE GUIDE Indicated for type 1 patients 14 and over. Prescription required. WARNING: Medtronic performed an evaluation of the MiniMed 670G system and determined that it
More informationMEDICAL POLICY Continuous Glucose Monitoring Systems and Insulin Pumps
POLICY: PG0177 ORIGINAL EFFECTIVE: 12/01/08 LAST REVIEW: 07/10/18 MEDICAL POLICY Continuous Glucose Monitoring Systems and Insulin Pumps GUIDELINES This policy does not certify benefits or authorization
More informationUSING THE MINIMED 670G SYSTEM. Instructions for the Experienced MiniMed 630G System User
USING THE MINIMED 670G SYSTEM Instructions for the Experienced MiniMed 630G System User This is a supplemental guide. For complete instructions and safety information, please see your MiniMed 670G System
More informationPATIENT TRAINING CHECKLIST MINIMED 670G SYSTEM
Technical Training Insulin Pump Infusion Set: Insulin Pump Model: BASIC FEATURES Patient has demonstrated understanding of: Button Functions Home Screen Menu review Status Screens Battery type/insertion
More informationApproved by: Integrated Health Quality Management Subcommittee Effective Date: Department of Origin: Integrated Healthcare Services.
Reference #: MC/L008 Page: 1 of 8 PRODUCT APPLICATION: PreferredOne Community Health Plan (PCHP) PreferredOne Administrative Services, Inc. (PAS) ERISA PreferredOne Administrative Services, Inc. (PAS)
More informationReport Reference Guide. THERAPY MANAGEMENT SOFTWARE FOR DIABETES CareLink Report Reference Guide 1
Report Reference Guide THERAPY MANAGEMENT SOFTWARE FOR DIABETES CareLink Report Reference Guide 1 How to use this guide Each type of CareLink report and its components are described in the following sections.
More informationDiabetes and Technology. Saturday, September 9, 2017 Aimee G sell, APRN, ANP-C, CDE
Diabetes and Technology Saturday, September 9, 2017 Aimee G sell, APRN, ANP-C, CDE Disclosure Speaker s Bureau: Janssan Pharmaceuticals Current Technology V-Go by Valeritas Continuous Sensors (personal
More informationAdvances in Diabetes Care Technologies
1979 Advances in Diabetes Care Technologies 2015 Introduction Insulin pump use: ~ 20% - 30% of patients with T1DM < 1% of insulin-treated patients with T2DM 2007 FDA estimates ~375,000 insulin pumps for
More informationCorporate Medical Policy
Corporate Medical Policy Continuous Monitoring of Glucose in the Interstitial Fluid File Name: Origination: Last CAP Review: Next CAP Review: Last Review: continuous_monitoring_of_glucose_in_the_interstitial_fluid
More informationReal-Time Continuous Glucose Monitoring: From Application to Evaluation
Real-Time Continuous Glucose Monitoring: From Application to Evaluation Gary Scheiner MS, CDE Owner/Director, Integrated Diabetes Services 333 E. Lancaster Ave., Suite 24 Wynnewood, PA 1996 (877) 735-3648
More informationMEDICAL POLICY Continuous Glucose Monitoring Systems and Insulin Pumps
POLICY: PG0177 ORIGINAL EFFECTIVE: 12/01/08 LAST REVIEW: 02/13/18 MEDICAL POLICY Continuous Glucose Monitoring Systems and Insulin Pumps GUIDELINES This policy does not certify benefits or authorization
More informationControl of Glycemic Variability for Reducing Hypoglycemia Jae Hyeon Kim
Control of Glycemic Variability for Reducing Hypoglycemia Jae Hyeon Kim Division of Endocrinology and Metabolism, Samsung Medical Center, Sungkyunkwan University School of Medicine Conflict of interest
More informationMaking the Most of Continuous Glucose Monitoring
Making the Most of Continuous Glucose Monitoring Gary Scheiner MS, CDE Owner & Clinical Director Integrated Diabetes Services LLC Wynnewood, PA AADE 2014 Diabetes Educator of the Year gary@integrateddiabetes.com
More informationContinuous Glucose Monitoring (CGM)
Continuous Glucose Monitoring (CGM) Date of Origin: 02/2001 Last Review Date: 07/26/2017 Effective Date: 07/26/2017 Dates Reviewed: 04/2004, 04/2005, 03/2006, 11/2006, 12/2007, 03/2008, 09/2008, 04/2009,
More informationContinuous Glucose Monitoring Devices Pharmacy Policy
Line of Business: All Line of Business Effective date: August 16, 2017 Revision date: August 16, 2017 Continuous Glucose Monitoring Devices Pharmacy Policy This policy has been developed through review
More informationContinuous Glucose Monitoring
Continuous Glucose Monitoring What is Continuous Glucose Monitoring? Blood glucose meters measure glucose in your blood and glucose sensors measure glucose levels in the fluid around the cells They are
More informationContinuous Glucose Monitoring
Continuous Glucose Monitoring Information about fully-subsidised continuous glucose monitoring for children and young people with type 1 diabetes Continuous glucose monitoring (CGM) can help in managing
More informationSeven Simple Steps to Start. Your Dexcom G4 PLATINUM System
Seven Simple Steps to Start Your Dexcom G4 PLATINUM System Receiver Sensor Applicator Transmitter Sensor Remove transmitter from tray and wait 10 minutes Do Not Throw Away Battery life ~ 6 months Charging
More informationReceiver and App Setup
Continuous Glucose Monitoring System Receiver and App Setup For training videos visit dexcom.com/medicare Overview Your Dexcom G5 Continuous Glucose Monitoring (CGM) System is made up of: Transmitter (Sensor
More informationAdvances in Diabetes Technology Part II: Analysis of Diabetes Self Management Devices and Support Tools
Advances in Diabetes Technology Part II: Analysis of Diabetes Self Management Devices and Support Tools Jennifer Trujillo, PharmD, FCCP, BCPS, CDE, BC ADM Associate Professor University of Colorado School
More informationUpdates in Diabetes Technology
Updates in Diabetes Technology Jessica Kirk, MSN, RN, CPN, CDE Nurse Manager, Endo ECHO No disclosures Disclosures 1 Objectives Distinguish patients appropriate for continuous glucose monitoring and insulin
More informationContinuous Glucose Monitoring System. Receiver Setup
Continuous Glucose Monitoring System Receiver Setup Overview Your Dexcom G5 Continuous Glucose Monitoring (CGM) System is made up of: Receiver What do I do with it? Review your readings. Set and receive
More informationPredicts and helps prevent lows with. zero fingersticks NOW FEATURING BASAL-IQ TECHNOLOGY
Predicts and helps prevent lows with * zero fingersticks NOW FEATURING BASAL-IQ TECHNOLOGY Basal-IQ Technology is not a substitute for active self-management of your diabetes. Please see back cover for
More informationFirst steps for success.
First steps for success. Getting to know continuous glucose monitoring (CGM). The Animas Vibe System is approved for persons age 2 and older. Important Safety Information The Animas Vibe Insulin Pump and
More informationAdvances in Diabetes Care Technologies
1979 Advances in Diabetes Care Technologies 2015 Introduction Roughly 20% - 30% of patients with T1DM and fewer than 1% of insulin-treated patients with T2DM use an insulin pump In 2007, the US FDA estimated
More informationGetting Started. Learning Guide. with Insulin Pump Therapy. PUMP Foundations. for the MiniMed 530G with Enlite
Getting Started with Insulin Pump Therapy for the MiniMed 530G with Enlite Learning Guide PUMP Foundations MiniMed 530G Insulin Pump Settings Form: We recommend that you record all settings on this form
More informationREPORT INTERPRETATION
REPORT INTERPRETATION: Interpreting ipro Professional Continuous Glucose Monitoring (CGM) Reports and Making Therapy Adjustments TARGET AUDIENCE The audience for this section is physicians, mid-level practitioners,
More informationContinuous Glucose Monitoring (CGM)
Continuous Glucose Monitoring (CGM) Background Info A1c Average glucose levels over previous 2-3 months Currently remains gold standard for determining control Indicator of risk for development of complications
More informationRELEASED. Clearing your active insulin
To clear all your settings: 1. Make sure the pump is not connected to your body. 2. Go to the Manage Settings screen. Menu > Utilities > Manage Settings 3. Simultaneously press and hold and until the Manage
More informationRELEASED. first steps. Icon Icon name What it means
Icon Icon name What it means Connection The connection icon appears green when the Sensor feature is on and your transmitter is successfully communicating with your pump. The connection icon appears gray
More informationNDSS Helpline
Continuous GLUCOSE MONITORING A guide to using CGM for children and young people with type 1 diabetes NDSS Helpline 1300 136 588 ndss.com.au The National Diabetes Services Scheme is an initiative of the
More informationAdvances in Technology in the Treatment of Diabetes Mellitus 2017 How far have we come-how far are we going? Is there a final frontier?
Advances in Technology in the Treatment of Diabetes Mellitus 2017 How far have we come-how far are we going? Is there a final frontier? Alan B Schorr DO FAAIM FACE www.sugardoc.com abs@sugardoc.com Disclosures
More informationCONTINUOUS OR INTERMITTENT GLUCOSE MONITORING IN INTERSTITIAL FLUID
FLUID Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs are dependent
More informationTHERAPY MANAGEMENT SOFTWARE FOR DIABETES
THERAPY MANAGEMENT SOFTWARE FOR DIABETES Report Report Interpretation Reference Guide Guide 2009 Medtronic MiniMed. All rights reserved. 6025274-012_a CareLink Pro Report Reference Guide 0 p.2 Adherence
More informationWhen Will CGM Replace SMBG? Roy W. Beck, MD, PhD. JAEB Center for Health Research Tampa, Florida
When Will CGM Replace SMBG? Roy W. Beck, MD, PhD JAEB Center for Health Research Tampa, Florida Financial Disclosures Dr. Beck does not have any personal conflicts of interest His employer, the JAEB Center
More informationState of California Health and Human Services Agency Department of Health Care Services
State of California Health and Human Services Agency Department of Health Care Services JENNIFER KENT Director EDMOND G. BROWN JR Governor DATE: N.L.: 03-0317 Index: Benefits TO: ALL COUNTY CALIFORNIA
More informationThe Growing Future of Diabetes: Insulin Pump Therapy in Type 1 and 2 Diabetes
The Growing Future of Diabetes: Insulin Pump Therapy in Type 1 and 2 Diabetes Sarah Dombrowski, PharmD, BCACP Pennsylvania Pharmacists Association 10/20/18 1 Objectives At the completion of this activity,
More informationTHERAPY MANAGEMENT SOFTWARE FOR DIABETES
THERAPY MANAGEMENT SOFTWARE FOR DIABETES Report Report Interpretation Reference Guide Guide 2007 Medtronic MiniMed. All rights reserved. 6025274-0U2 120707 CareLink Pro Report Reference Guide 0 p.2 Sensor
More informationTechnology in Diabetes Care: Emerging Level
Technology in Diabetes Care: Emerging Level Charlotte Parsons ARNP, CDE Christine Fisher, RD, CD, CDE, CPT WADE April 26, 2019 Disclosures to Participants Notice of Requirements for Successful Completion:
More informationMEDICAL POLICY SUBJECT: CONTINUOUS GLUCOSE MONITORING SYSTEMS/ EXTERNAL INSULIN PUMP THERAPY FOR DIABETES EFFECTIVE DATE: 08/17/17
MEDICAL POLICY SUBJECT: CONTINUOUS GLUCOSE MONITORING PAGE: 1 OF: 11 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product,
More informationClinical Value and Evidence of Continuous Glucose Monitoring
Clinical Value and Evidence of Continuous Glucose Monitoring 9402313-012 Objective To review the clinical value and the recent clinical evidence for Professional and Personal CGM Key Points CGM reveals
More informationDIABETES TECHNOLOGY: WHERE ARE WE NOW AND WHERE ARE WE GOING? Presented by: Tom Brobson
DIABETES TECHNOLOGY: WHERE ARE WE NOW AND WHERE ARE WE GOING? Presented by: Tom Brobson March 3 rd, 2018 Who is this guy? Accelerating Progress 1 Oh that guy! Accelerating Progress 2 STATE OF T1D CARE
More information10:20 AM March 5, B 100% 235 u. 124 mg/dl 3 HRS INSULIN ON BOARD:
DEXCOM G5 MOBILE CGM COMPATIBLE B 100% 235 u INSULIN ON BOARD: OPTIONS 10:20 AM March 5, 2017 400 350 300 250 200 150 100 50 1.1 u 1:09 hrs BOLUS 124 mg/dl 3 HRS The pump that gets updated, not outdated.
More informationPump and Sensor Data Interpretation. Irl B. Hirsch, MD University of Washington School of Medicine
Pump and Sensor Data Interpretation Irl B. Hirsch, MD University of Washington School of Medicine Dualities Research: Medtronic Diabetes Consulting: Abbott Diabetes Care, BD, Bigfoot, Roche Raise Your
More informationThe Realities of Technology in Type 1 Diabetes
The Realities of Technology in Type 1 Diabetes May 6, 2017 Rosanna Fiallo-scharer, MD Margaret Frederick, RN Disclosures I have no conflicts of interest to disclose I will discuss some unapproved treatments
More informationObjectives. The Problem. We ve come a LONG way, Innovations in Diabetes Care and Management. Barbara Walz, RN, BSN, CDE April 26, 2018
Objectives Innovations in Diabetes Care and Management Barbara Walz, RN, BSN, CDE April 26, 2018 1. Briefly discuss the history of diabetes management over the past 100 years 2. Describe the impact of
More informationDexcom Current and Future Technology Innovations. Jorge Valdes Chief Technical Officer
Dexcom Current and Future Technology Innovations 2015 Jorge Valdes Chief Technical Officer G5 App Sensor (Same as G4) Indicated for adults and children down to Age 2 years Tiny insertion needle (26Ga)
More informationArtificial Pancreas Device Systems. Populations Interventions Comparators Outcomes Individuals: With type 1 diabetes
Protocol Artificial Pancreas Device Systems Medical Benefit Effective Date: 07/01/18 Next Review Date: 01/20 Preauthorization Yes Review Dates: 03/15, 03/16, 03/17, 01/18, 05/18, 01/19 Preauthorization
More informationCARELINK PERSONAL ACTIONABLE INSIGHTS FOR BETTER DIABETES MANAGEMENT CARELINK REPORTS GUIDE
CARELINK PERSONAL ACTIONABLE INSIGHTS FOR BETTER DIABETES MANAGEMENT CARELINK REPORTS GUIDE CARELINK PERSONAL ACTIONABLE INSIGHTS FOR BETTER DIABETES MANAGEMENT As part of your diabetes therapy you have
More informationDIABETES & ENDOCRINE DIABETES TECHNOLOGY: HOW TO STAY CURRENT WITH ONGOING TECHNOLOGY ADVANCEMENT
DIABETES TECHNOLOGY: HOW TO STAY CURRENT WITH ONGOING TECHNOLOGY ADVANCEMENT Min-Jye Chen, MD Endocrinology Diabetes Management of the School-Aged Child Provided by Texas Children s Hospital Provider #18-267764-A
More informationDiabetes Technology in Irl B. Hirsch, MD University of Washington School of Medicine Seattle, WA
Diabetes Technology in 2018 Irl B. Hirsch, MD University of Washington School of Medicine Seattle, WA Dualities Research: Medtronic Diabetes Consulting: Abbott Diabetes Care, BD, Bigfoot, Roche Let s First
More informationMEDICAL POLICY SUBJECT: CONTINUOUS GLUCOSE MONITORING SYSTEMS/ EXTERNAL INSULIN PUMP THERAPY FOR DIABETES EFFECTIVE DATE: 08/17/17, 08/16/18
MEDICAL POLICY SUBJECT: CONTINUOUS GLUCOSE MONITORING PAGE: 1 OF: 12 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product (including
More informationFor Safe and Effective Diabetes Management
For Safe and Effective Diabetes Management How FreeStyle Libre Works FreeStyle Libre is a system for continuous glucose monitoring (CGM) that gives you easy access to your glucose numbers. CGM has been
More informationIntroducing DEXCOM STUDIO INTUITIVE. FOCUSED. SIMPLIFIED. HELP TAKE the GUESSWORK OUT of GLUCOSE PATTERN MANAGEMENT
DEXCOM STUDIO Introducing Continuous Glucose Monitoring Software INTUITIVE. FOCUSED. SIMPLIFIED. HELP TAKE the GUESSWORK OUT of GLUCOSE PATTERN MANAGEMENT GLUCOSE PATTERN MANAGEMENT Pre and Post Prandial
More informationArtificial Pancreas Device Systems. Populations Interventions Comparators Outcomes. pump. pump
Protocol Artificial Pancreas Device Systems (10130) Medical Benefit Effective Date: 04/01/18 Next Review Date: 01/19 Preauthorization Yes Review Dates: 03/15, 03/16, 03/17, 01/18 Preauthorization is required.
More informationOptimizing Therapy and Clinical Outcomes Using Real-Time Continuous Glucose Monitoring (AADE PRODUCT THEATRE) August 7, 2014 Orlando, FL
Optimizing Therapy and Clinical Outcomes Using Real-Time Continuous Glucose Monitoring (AADE PRODUCT THEATRE) August 7, 2014 Orlando, FL Welcome and Introduction Orlando, FL August 7 th, 2014 Keri Weindel,
More informationInsert your sensor and attach the Transmitter (see pg5-6. Enter 2 calibrations after 2 hour start up period (5 min apart with BG meter)
1 Dexcom Start Date: Receiver out of Warranty (12months): Transmitter out of Warranty (6months): Your high alert is set at: Your low alert is set at: Date of return to clinic: CGM is a tool that tracks
More informationArtificial Pancreas Device System (APDS)
Medical Policy Manual Durable Medical Equipment, Policy No. 77 Artificial Pancreas Device System (APDS) Next Review: October 2019 Last Review: October 2018 Effective: November 1, 2018 IMPORTANT REMINDER
More informationNext steps for success.
Next steps for success. More tips for using CGM* training course. The Animas Vibe System is approved for persons age 2 and older. *Continuous Glucose Monitoring Important Safety Information The Animas
More informationHow to Transfer Your Settings
How to Transfer Your Settings for your Replacement MiniMed 530G System Let s get started! Step 1: Before you send your original pump back, copy your current settings onto the Insulin Pump Settings Form.
More informationWOULD YOU LIKE TO REDUCE THE FEAR OF HYPOGLYCAEMIA FOR YOUR PATIENTS?
WOULD YOU LIKE TO REDUCE THE FEAR OF HYPOGLYCAEMIA FOR YOUR PATIENTS? THE ONLY SYSTEM CLINICALLY PROVEN TO REDUCE HYPOGLYCAEMIA MINIMED 640G SYSTEM WITH SMARTGUARD TECHNOLOGY 1 HYPOGLYCAEMIA IS CHALLENGING
More informationInterpreting the charts & graphs
Report reference guide mg/dl The diasend solution Interpreting the charts & graphs diasend is a universal cloud-based diabetes data management system, that enables you to upload data from meters, pumps
More informationTHE ONLY SYSTEM^ CLINICALLY PROVEN TO REDUCE HYPOGLYCAEMIA
THE ONLY SYSTEM^ CLINICALLY PROVEN TO REDUCE HYPOGLYCAEMIA MINIMED 640G system^ with SmartGuard technology HYPOGLYCAEMIA IS CHALLENGING FOR GLYCAEMIC CONTROL 1 AND quality of life 2 Achieving good glucose
More informationContinuous Glucose Monitoring (CGM) Dexcom G6 Training for Healthcare Professionals and Patients
ssociation of Children s Diabetes Continuous Glucose Monitoring (CGM) Dexcom G6 Training for Healthcare Professionals and Patients 1 ssociation of Children s Diabetes Contents Chapter Page no. Chapter
More informationDr Sander Zwart MD, FACP, ECNU Arizona-AACE 2016 Annual Meeting
Dr Sander Zwart MD, FACP, ECNU Arizona-AACE 2016 Annual Meeting Disclaimers None Except products and software discussed are all proprietary, so if I mention a brand product it is because there is no other
More informationDisclosures. Glycemic Control in the Intensive Care Unit. Objectives. Hyperglycemia. Hyperglycemia. History. No disclosures
Disclosures Glycemic Control in the Intensive Care Unit No disclosures Jorie Frasiolas, Pharm.D., BCPS Clinical Pharmacy Manager, CTICU NewYork-Presbyterian Hospital Columbia University Medical Center
More informationIncorporating CGM Into Clinical Decision
Incorporating CGM Into Clinical Decision Making Etie Moghissi, MD, FACE Clinical Associate Professor, David Geffen School of Medicine UCLA 1 It is Time to Think Beyond A1C HbA1c is simple to administer
More informationPumps & Sensors made easy. OPADA ALZOHAILI MD FACE Endocrinology Assistant Professor Wayne State University
Pumps & Sensors made easy OPADA ALZOHAILI MD FACE Endocrinology Assistant Professor Wayne State University DeFronzo RA. Diabetes. 2009;58:773-795. Ominous Octet Relationship of b-cell Dysfunction and Development
More informationParadigm/Guardian CGM Screens. CareLink Online Reports. Make Your Own Jackson Pollack. CGM by Jackson Pollack. How To Read CGM Screens/Reports
CGM by Jackson Pollack One Pollack sold for $140 million in 1996! Make Your Own Jackson Pollack How To Read CGM Screens/Reports For only $1,000! Paradigm/Guardian CGM Screens On-Screen Reports 3 / 6 /
More informationTechnology in Diabetes Management Irl B. Hirsch, MD University of Washington
Technology in Diabetes Management 2016 Irl B. Hirsch, MD University of Washington Dualities Research: Helmsley Charitable Trust, JDRF, ADA, NIDDK, CDC Consulting: Abbott, Roche, Intarcia Raise Your Hand
More informationAdvances Towards the Bionic Pancreas.
Advances Towards the Bionic Pancreas. Ron Brazg MD, FACE Rainier Clinical Research Center Renton, WA DISCLOSURES Rainier Clinical Research Center is an independent research facility not directly affiliated
More informationWhat is a CGM? (Continuous Glucose Monitor) The Bionic Pancreas Is Coming
The Bionic Pancreas Is Coming Montana Diabetes Professional Conference October 23, 2014 H. Peter Chase, MD Professor of Pediatrics University of Colorado Barbara Davis Center Stanford: Bruce Buckingham,
More informationPROTOCOL FOR HYBRID CLOSED LOOP TECHNOLOGY
PROTOCOL FOR HYBRID CLOSED LOOP TECHNOLOGY Situations Requiring Special Consideration and Resource Documents Second Edition MiniMed 67G System Medical Education TABLE OF CONTENTS A PROTOCOL FOR HYBRID
More informationApplications of Technologies to Your Patient. Irl B. Hirsch, MD Professor of Medicine University of Washington School of Medicine Seattle, Washington
Applications of Technologies to Your Patient Irl B. Hirsch, MD Professor of Medicine University of Washington School of Medicine Seattle, Washington Disclosures Consultant: Abbott Diabetes Care, Roche
More informationCOMPANY OVERVIEW. April 26, 2018
COMPANY OVERVIEW April 26, 2018 SAFE HARBOR & NON-GAAP FINANCIAL MEASURES Forward Looking Statements Certain statements in this presentation constitute forward-looking statements, including, without limitation,
More informationssociation of Children s Diabetes Clinicians Clinicians Continuous Glucose Monitoring (CGM) Training for Healthcare Professionals and Patients
ssociation of Children s Diabetes Continuous Glucose Monitoring (CGM) Training for Healthcare Professionals and Patients 1 ssociation of Children s Diabetes Contents Chapter Page no. STEP 1...3 Getting
More informationQuick Reference Guide
FLASH GLUCOSE MONITORING SYSTEM Quick Reference Guide IMPORTANT USER INFORMATION Before you use your System, review all the product instructions and the Interactive Tutorial. The Quick Reference Guide
More informationWHEN YOUR PANCREAS IS NOT A HAPPY CAMPER A PRESENTATION ON DIABETES MANAGEMENT IN THE CAMP SETTING AMANDA COSCHI, BSCN, RN, CDE
WHEN YOUR PANCREAS IS NOT A HAPPY CAMPER A PRESENTATION ON DIABETES MANAGEMENT IN THE CAMP SETTING AMANDA COSCHI, BSCN, RN, CDE MAY 5, 2018 OBJECTIVES Strong understanding of diabetes and its management
More informationWOULD YOU LIKE MORE CONFIDENCE IN YOUR HYPOGLYCAEMIC CONTROL? SMARTGUARD. PROVIDES PREDICTIVE PROTECTION
WOULD YOU LIKE MORE CONFIDENCE IN YOUR HYPOGLYCAEMIC CONTROL? SMARTGUARD. PROVIDES PREDICTIVE PROTECTION 1,2 MINIMED 640G WITH SMARTGUARD HAVE YOU CONSIDERED THE REAL IMPACT HYPOGLYCAEMIA HAS ON YOUR LIFE?
More informationQuick Reference Guide
FLASH GLUCOSE MONITORING SYSTEM Quick Reference Guide FreeStyle LibreLink app A FreeStyle Libre product IMPORTANT USER INFORMATION Before you use your System, review all the product instructions and the
More informationMedical Education. Personal Continuous Glucose Monitoring Protocol. Innovating for life.
Personal Continuous Glucose Monitoring Protocol A Guide to Continuous Glucose Monitoring Integrated with Insulin Pump Therapy Includes Alert and Trend Management as well as Threshold Medical Education
More informationNon-Invasive Glucose Monitoring. Kevin Walls April 12, :30 PM-7:30 PM.
Non-Invasive Glucose Monitoring Kevin Walls April 12, 2018 6:30 PM-7:30 PM. Technology is evolving Technology is evolving at such a rapid rate it s hard to keep up. Imagine living a healthier life without
More information